Close
Smartlab Europe
Inizio Ignite

Cmed to Demonstrate how encapsia® Transforms Clinical Trial Data Management, Capture and Reporting at Leading Oncology Meetings

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Innovations Advancing Oral Drug Delivery for Complex Molecules

Deep dive into the physiological and biochemical obstacles that hinder the oral administration of biologics and large molecules, and the innovations designed to overcome them.

Nanotechnology Applications in Drug Delivery Development

Investigation into the role of nanoscale carriers in enhancing therapeutic precision, overcoming biological barriers, and enabling the delivery of sensitive genetic materials.

Controlled Release Drug Formulations Shaping Patient Care

An exploration of how advanced dosing mechanisms maintain therapeutic stability, reduce side effects, and improve patient compliance in the management of chronic conditions.
- Advertisement -

Cmed, an oncology focused, innovative technology-led CRO, announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA.

As a full-service CRO, Cmed has a strong reputation in delivering complex and demanding clinical trials across numerous oncology types, including various haematological indications, immuno-oncology, breast, lung, prostate and colorectal. Cmed has combined this deep understanding of the needs of oncology studies with its encapsia clinical data suite, allowing the company to work with sponsors to set-up and conduct trials smarter and more efficiently.
David Connelly, Chief Executive Officer, Cmed, commented: “At Cmed, with 16 years’ experience in oncology clinical trials, we truly understand the importance and practical challenges of conducting oncology clinical studies”

“During these pivotal meetings, we are excited to be able to showcase our encapsia clinical data suite and demonstrate to sponsors the benefits of immediate access to real-time clinical data with live, actionable insights and analytics. These include helping to enroll patients more accurately while bringing improvements to monitoring patient safety, generating high quality data and driving more timely decision-making.”

Visitors are invited to join Cmed at booth #15 during Clinical Operations in Oncology Trials Europe and booth #512 during the ASH Annual Meeting. To schedule a meeting
with the Cmed team, please contact info@cmedresearch.com

For further information on Cmed, please visit www.cmedresearch.com

About Cmed
Cmed is an innovative, full service technology-led CRO. Cmed brings together experienced people and technology, providing customers with a friendly, proactive service, and delivers this service using advanced clinical data capture, management and reporting software and processes. Cmed’s new generation clinical data suite, encapsia®, streamlines the capture, management and reporting of clinical data, saving customers time and money. Clinical data can be captured flexibly by eSource, multi-media and web eDC, while being displayed in live visual insights, providing live analytics, and allowing within suite audit trailed actions. It is fully compliant with regulatory guidelines, and allows integration with existing systems.

 

Latest stories

Related stories

Innovations Advancing Oral Drug Delivery for Complex Molecules

Deep dive into the physiological and biochemical obstacles that hinder the oral administration of biologics and large molecules, and the innovations designed to overcome them.

Nanotechnology Applications in Drug Delivery Development

Investigation into the role of nanoscale carriers in enhancing therapeutic precision, overcoming biological barriers, and enabling the delivery of sensitive genetic materials.

Controlled Release Drug Formulations Shaping Patient Care

An exploration of how advanced dosing mechanisms maintain therapeutic stability, reduce side effects, and improve patient compliance in the management of chronic conditions.

Advanced Drug Delivery Systems in Modern Therapeutics

Exploration of how sophisticated delivery mechanisms enhance medical efficacy, reduce side effects, and enable personalized treatment across oncology, neurology, and chronic disease management.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »